View Post

Early intervention needed to help breast cancer patients manage ‘chemobrain’ symptoms

In In The News by Barbara Jacoby0 Comments

From: news-medical.net More support is needed to help breast cancer patients and survivors manage ‘chemobrain’ symptoms, such as memory loss, short attention span and mental confusion, according to a study led by researchers from the National University of Singapore (NUS). The study involving 131 female breast cancer patients in Singapore revealed that almost half had suffered from cognitive decline at some …

View Post

Could post-surgery healing process trigger cancer spread in breast cancer?

In In The News by Barbara Jacoby

By: CATHERINE THORBECKE From: abcnews.go.com If a new study in mice ends up holding true for humans, there may be a new explanation for why breast cancer can spread after surgery. The wound-healing process may make the immune system too busy to catch cancer cells that travel around the body. The same study proposed, however, that taking nonsteroidal anti-inflammatory drugs (NSAIDs), however, could help …

View Post

Cancer Can Start To Develop Fifty Years Before Diagnosis

In In The News by Barbara Jacoby

By: Victoria Forster From: forbes.com Scientists studying kidney cancer have found that the first DNA damage eventually leading to cancer can occur as early as childhood, in some cases fifty years before diagnosis. In a trio of studies simultaneously published on Thursday in the journal Cell, researchers have provided vital new information as to how kidney cancer begins, evolves and progresses, which they hope will lead …

View Post

Cancer surgery can awaken tumor cells, but in mice a cheap pill stops metastasis

In In The News by Barbara Jacoby

By: Sharon Begley From: statnews.com Bottles of aspirin and ibuprofen won’t soon be carrying labels saying they reduce the risk of breast cancer recurrence after surgery, but that kind of cheap drugstore remedy stemmed metastasis in a startling new study in mice. Although lumpectomy is often curative, in some cases it can activate tiny, distant tumors that had been held …

View Post

Blood test could detect people’s breast cancer risk at birth and save millions of lives, research claims

In In The News by Barbara Jacoby

By: Sun Reporter From: thesun.co.uk Doctor Anna Rose’s revolutionary research could mean that previously overlooked information could now be used to actually identify cancers at an earlier stage. A SIMPLE blood test costing a few pounds could detect the risk of cancer at birth. Researcher Dr Anna Rose, 31, of the John Radcliffe Hospital in Oxford, found a test on …

View Post

IBM takes on drug-resistant cancers

In In The News by Barbara Jacoby

By: Josh Baxt From: medcitynews.com Computer giant IBM has a side business in the life sciences, and it’s doing interesting work on cancer. In a recent paper published in the Journal of the American Chemical Society (JACS), researchers at IBM Healthcare and Life Sciences outlined how new polymers can selectively destroy cancer cells by slicing them open. “They poke a …

View Post

Pending Legislation Pertaining to Affordable Prescription Drug Coverage

In Breast Cancer, Creating Happiness, Recent Posts by Barbara Jacoby

In my continuing mission as a patient advocate, I include in my daily news review any information that I may find that deals with financial matters pertaining to cancer patient treatments. The purpose is to alert patients and medical professionals to information that may be of potential help in dealing with this most important aspect that affects a person’s treatment. …

View Post

New ACR/SBI Breast Cancer Screening Guidelines Call for Significant Changes to Screening Process

In In The News by Barbara Jacoby

New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such.  The ACR and SBI now call for all women to have a risk assessment at age 30 to see if screening earlier than age …

View Post

ONC201 Trial Begins for Endometrial and Breast Cancer

In In The News by Barbara Jacoby

Oncoceutics, Inc. announced today that the first patient has been treated in a clinical trial of ONC201 for patients with certain types of advanced endometrial and breast cancer. The Phase II trial is led by Alexandra Zimmer, MD, Assistant Research Physician at the Women’s Malignancies Branch at the National Cancer Institute (NCI) Center for Cancer Research, part of the National …

View Post

Study identifies predictors of immunotherapy response in head and neck cancer

In In The News by Barbara Jacoby

Source: Dana-Farber Cancer Institute From: Redington Newsdesk Dana-Farber Cancer Institute scientists say they have identified factors that predict improved response and survival in patients with head and neck cancers treated with checkpoint inhibitor immunotherapy. Two immunotherapy agents known as checkpoint inhibitors have been approved to treat patients whose disease is resistant to standard platinum-based chemotherapy. However, only a minority of …